DE69222570D1 - Phosphonsäurederivate, Verfahren zur Herstellung und ihre Verwendung - Google Patents

Phosphonsäurederivate, Verfahren zur Herstellung und ihre Verwendung

Info

Publication number
DE69222570D1
DE69222570D1 DE69222570T DE69222570T DE69222570D1 DE 69222570 D1 DE69222570 D1 DE 69222570D1 DE 69222570 T DE69222570 T DE 69222570T DE 69222570 T DE69222570 T DE 69222570T DE 69222570 D1 DE69222570 D1 DE 69222570D1
Authority
DE
Germany
Prior art keywords
phosphonic acid
isobutyl
preparation
acid derivatives
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69222570T
Other languages
English (en)
Other versions
DE69222570T2 (de
Inventor
Mitsuhiro Wakimasu
Masaaki Mori
Akira Kawada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE69222570D1 publication Critical patent/DE69222570D1/de
Publication of DE69222570T2 publication Critical patent/DE69222570T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69222570T 1991-06-13 1992-06-10 Phosphonsäurederivate, Verfahren zur Herstellung und ihre Verwendung Expired - Fee Related DE69222570T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14209991 1991-06-13
JP4089111A JPH05105698A (ja) 1991-06-13 1992-04-09 ホスホン酸誘導体、その製造法および用途

Publications (2)

Publication Number Publication Date
DE69222570D1 true DE69222570D1 (de) 1997-11-13
DE69222570T2 DE69222570T2 (de) 1998-02-12

Family

ID=26430544

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69222570T Expired - Fee Related DE69222570T2 (de) 1991-06-13 1992-06-10 Phosphonsäurederivate, Verfahren zur Herstellung und ihre Verwendung

Country Status (6)

Country Link
US (2) US5330978B1 (de)
EP (1) EP0518299B1 (de)
JP (1) JPH05105698A (de)
AT (1) ATE159029T1 (de)
CA (1) CA2071106A1 (de)
DE (1) DE69222570T2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9300048D0 (en) 1993-01-04 1993-03-03 Wellcome Found Endothelin converting enzyme inhibitors
US5608078A (en) * 1993-03-30 1997-03-04 Merrell Pharmaceuticals Inc. Phosphonomethyldipeptides and process for preparation thereof
EP0618224A1 (de) * 1993-03-30 1994-10-05 Merrell Dow Pharmaceuticals Inc. Phosophonomethyldipeptide
WO1994028012A1 (en) * 1993-05-28 1994-12-08 Warner-Lambert Company Hydroxamate inhibitors of endothelin converting enzyme
FR2707089B1 (fr) * 1993-06-30 1995-08-18 Adir Nouveaux dérivés d'acide phosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
IT1274673B (it) * 1994-04-14 1997-07-24 Zambon Spa Derivati dell'acido fosfonico utili nel trattamento delle malattie car.iovascolari
US5658902A (en) * 1994-12-22 1997-08-19 Warner-Lambert Company Quinazolines as inhibitors of endothelin converting enzyme
US5958905A (en) 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
WO1998042308A1 (fr) * 1997-03-25 1998-10-01 Kao Corporation Agents de prevention du vieillissement de la peau
JP3973748B2 (ja) 1998-01-14 2007-09-12 花王株式会社 発毛抑制剤
DE60135560D1 (de) * 2000-07-19 2008-10-09 Novartis Ag Valsartan salze
US9078808B2 (en) * 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379146A (en) * 1981-02-17 1983-04-05 Merck & Co., Inc. Substituted phosphonamides as antihypertensives
US4432972A (en) * 1981-08-03 1984-02-21 E. R. Squibb & Sons, Inc. Phosphonamidate compounds

Also Published As

Publication number Publication date
US5330978B1 (en) 1996-06-18
EP0518299A3 (en) 1993-04-07
JPH05105698A (ja) 1993-04-27
ATE159029T1 (de) 1997-10-15
DE69222570T2 (de) 1998-02-12
US5330978A (en) 1994-07-19
EP0518299B1 (de) 1997-10-08
USRE35886E (en) 1998-09-01
CA2071106A1 (en) 1992-12-14
EP0518299A2 (de) 1992-12-16

Similar Documents

Publication Publication Date Title
ATE134998T1 (de) Diphenylmethanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE121939T1 (de) Ascorbinsäure-tocopheryl-phosphatdiester zur hemmung der maillard-reaktion.
ES2070994T3 (es) Profarmaco de dopamina.
US5330978B1 (en) Phosphonic acid derivatives and use thereof
ATE71083T1 (de) L-dopa-derivate oder ihre saeureadditionssalze, verfahren zu ihrer herstellung und ihre verwendung.
NO303265B1 (no) Xantinderivater samt anvendelse av xantinderivater for fremstilling av et terapeutisk middel mot Parkinson's sykdom
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE69110828D1 (de) Heterozyklische Aminderivate, deren Herstellung und deren Verwendung.
EP0354568A3 (de) Catechol-Derivate
ATE149165T1 (de) Stickstoff enthaltende bizyklische derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ATE41659T1 (de) Benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
DE3762969D1 (de) Piperazinverbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und verwendung.
FI891155A (fi) Menetelmä terapeuttisesti käyttökelpoisten 4,5,6,7-tetrahydroisotiatsolo/4,5-c/pyridiini-johdannaisten ja niiden isomeerien ja happoadditiosuolojen valmistamiseksi
DE3767533D1 (de) D-nor-7-ergolinderivate, verfahren zu ihrer herstellung, pharmazeutische zubereitung und verwendung.
NO963374L (no) Substituerte 4H-pyraner
DK424888D0 (da) Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater
DE69328585D1 (de) Neue Alkaloidderivate, ihre Verwendung und diese enthaltende pharmazeutische Formulierungen
IT1229846B (it) Esteri di catecolammine.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee